State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
75 hedge funds and large institutions have $144M invested in State Street SPDR S&P Pharmaceuticals ETF in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $132M → $144M (+$11.8M)
12.77% less ownership
Funds ownership: 75.28% → 62.51% (-13%)
Holders
75
Holding in Top 10
–
Calls
$3.41M
Puts
$1.2M
Top Buyers
| 1 | +$6.84M | |
| 2 | +$3.37M | |
| 3 | +$2.56M | |
| 4 |
Jane Street
New York
|
+$1.33M |
| 5 |
LPL Financial
San Diego,
California
|
+$1.26M |
Top Sellers
| 1 | -$21M | |
| 2 | -$4.18M | |
| 3 | -$2.65M | |
| 4 |
CI
CX Institutional
Auburn,
Indiana
|
-$2.26M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.93M |
